8 results
Pulmonary Hypertension Algorithm - Matthew Watto, MD
#Diagnosis #Management #Pulmonary #Hypertension #PAH #Workup #Evaluation #Algorithm #Differential #Curbsiders
Pulmonary Hypertension ... Algorithm - Matthew ... MD #Diagnosis #Management ... #Pulmonary #Hypertension ... #PAH #Workup #Evaluation
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
prescribing and management ... in Pulmonary Arterial ... Hypertension (PAH ... #Management #Algorithm ... #treatment #pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... LAMA: long-acting ... #Management #Pulmonary ... COPD #GOLD2017 #LAMA
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Medical Treatment Algorithm ... long-acting β2-agonist; LAMA ... COPD #Treatment #Algorithm ... #Management #Pulmonary ... #SAMA #ICS #Pharmacology
Atrial Fibrillation Overview

Symptoms:
Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

1. Why?
Cardiac:
• Valvular heart disease
•
Atrial Fibrillation ... intolerance, chest pain, near-syncope ... Noncardiac: • Pulmonary ... #Cardiology #Management ... #Algorithm
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
Hypertension (PAH ... ) Management Algorithm ... #Hypertension #PAH ... #Management #Algorithm ... #treatment #pharmacology
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
Atrial Fibrillation ... intolerance, chest pain, near-syncope ... Noncardiac: • Pulmonary ... First episode or PAF ... AFib #diagnosis #management
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
, INC risk PE, Pulmonary ... amyloidosis, PAH ... Symptomatic: artificial tears ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management